English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어
LiminalBio's profile picture. Liminal BioSciences is a development-stage biopharmaceutical company focused on GPCR targets. See our social media community guidelines at http://bit.ly/2NfeNWx

Liminal BioSciences

@LiminalBio

Liminal BioSciences is a development-stage biopharmaceutical company focused on GPCR targets. See our social media community guidelines at http://bit.ly/2NfeNWx

334Posts 324Followers 128Following
You might like
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Sep 26, 2023

Liminal BioSciences announces completion of the plan of arrangement with Structured Alpha LP. loom.ly/e_tMVNE; read more below:-

LiminalBio's tweet image. Liminal BioSciences announces completion of the plan of arrangement with Structured Alpha LP. loom.ly/e_tMVNE; read more below:-
0
0
0
0
79
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Sep 20, 2023

Liminal Biosciences receives final court order for plan of arrangement with Structured Alpha LP. loom.ly/_-QOHdI; read more below:-

LiminalBio's tweet image. Liminal Biosciences receives final court order for plan of arrangement with Structured Alpha LP. loom.ly/_-QOHdI; read more below:-
0
0
0
0
51
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Sep 15, 2023

Liminal Biosciences Shareholders approve plan of arrangement with Structured Alpha LP. loom.ly/jmuqJRc; read more below:

LiminalBio's tweet image. Liminal Biosciences Shareholders approve plan of arrangement with Structured Alpha LP. loom.ly/jmuqJRc; read more below:
0
0
0
0
42
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Sep 12, 2023

Liminal Biosciences files amended schedule 13E-3 and supplement to the management information circular. loom.ly/kQOr7Eo; read more below:

LiminalBio's tweet image. Liminal Biosciences files amended schedule 13E-3 and supplement to the management information circular. loom.ly/kQOr7Eo; read more below:
0
0
0
0
53
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Aug 17, 2023

Liminal Biosciences obtains interim order for proposed arrangement with Structured Alpha LP; read more: loom.ly/7jFE1zk

LiminalBio's tweet image. Liminal Biosciences obtains interim order for proposed arrangement with Structured Alpha LP; read more: loom.ly/7jFE1zk
0
0
0
0
36
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Aug 9, 2023

Liminal BioSciences Reports Second Quarter Financial Results 2023. Read more; loom.ly/1NoU9H8

LiminalBio's tweet image. Liminal BioSciences Reports Second Quarter Financial Results 2023. Read more; loom.ly/1NoU9H8
0
0
0
0
50
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Jul 12, 2023

Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP. Under the terms of the agreement Liminal BioSciences minority shareholders to receive US$8.50 in cash per share. Read more: loom.ly/pwBQlZ4

LiminalBio's tweet image. Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP. Under the terms of the agreement Liminal BioSciences minority shareholders to receive US$8.50 in cash per share. Read more: loom.ly/pwBQlZ4
0
0
0
0
53
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Jun 6, 2023

Liminal BioSciences Announces Voting Results of its 2023 Annual General Meeting of Shareholders. Read more: loom.ly/1QQWzcU

LiminalBio's tweet image. Liminal BioSciences Announces Voting Results of its 2023 Annual General Meeting of Shareholders. Read more: loom.ly/1QQWzcU
0
0
0
0
60
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Jun 2, 2023

We are pleased to have nominated a lead preclinical candidate, LMNL6326, for the development of its OXER1 antagonist program, targeting the treatment of eosinophil-driven diseases, and provided an R&D update on all three of our #GPCR development programs. lnkd.in/eHmkqfDD

0
0
1
0
88
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
May 9, 2023

Liminal BioSciences Reports First Quarter Financial Results 2023. Read More: loom.ly/wjPxZvQ

LiminalBio's tweet image. Liminal BioSciences Reports First Quarter Financial Results 2023. Read More: loom.ly/wjPxZvQ
0
0
1
0
52
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
May 8, 2023

The Special Committee of the Board of Directors of Liminal Biosciences Retains an Independent Financial Advisor in Response to Unsolicited Non-Binding Transaction Proposal. Read more: loom.ly/orwLdVw

LiminalBio's tweet image. The Special Committee of the Board of Directors of Liminal Biosciences Retains an Independent Financial Advisor in Response to Unsolicited Non-Binding Transaction Proposal. Read more: loom.ly/orwLdVw
0
0
0
0
44
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Apr 5, 2023

Liminal Biosciences Confirms Receipt of Unsolicited Non-Binding Transaction Proposal. Read the full press release here: loom.ly/MoMv1Tg #GPCR #BioTechNews $LMNL

LiminalBio's tweet image. Liminal Biosciences Confirms Receipt of Unsolicited Non-Binding Transaction Proposal. Read the full press release here: loom.ly/MoMv1Tg #GPCR #BioTechNews $LMNL
0
0
0
0
85
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Mar 15, 2023

Today as part of our Q4 and full year 2022 earnings press release, we shared details of our new #GPR40 Agonist development Program. Read more about our pipeline here: loom.ly/odXnUDo #LMNL #GPCR #NASDAQ

LiminalBio's tweet image. Today as part of our Q4 and full year 2022 earnings press release, we shared details of our new #GPR40 Agonist development Program. Read more about our pipeline here: loom.ly/odXnUDo #LMNL #GPCR #NASDAQ
0
0
1
0
57
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Mar 14, 2023

Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 #FinancialResults on March 15, 2023 and host a conference call and webcast to discuss financial results at 8:30 am (ET) on Thursday March 16, 2023. Read more: loom.ly/Lezknlw #NASDAQ #GPCR

LiminalBio's tweet image. Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 #FinancialResults on March 15, 2023 and host a conference call and webcast to discuss financial results at 8:30 am (ET) on Thursday March 16, 2023. Read more: loom.ly/Lezknlw #NASDAQ #GPCR
0
1
1
0
45
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Mar 10, 2023

Our CEO, Bruce Pritchard and President, Patrick Sartore will be attending #BIOEuropeSpring this month. Join us in Basel March 20-22, 2023 and request a meeting though the BIO Partnering Platform: bit.ly/BioEuropeSprin… #LMNL #NASDAQ #GPCR

LiminalBio's tweet image. Our CEO, Bruce Pritchard and President, Patrick Sartore will be attending #BIOEuropeSpring this month. Join us in Basel March 20-22, 2023 and request a meeting though the BIO Partnering Platform: bit.ly/BioEuropeSprin… #LMNL #NASDAQ #GPCR
0
0
3
0
105
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Mar 8, 2023

We are passionate about creating a culture in which women can develop & thrive. We do this through providing opportunities for mentorship & ensuring we #embraceequity throughout the organisation. This year we would like to highlight experiences of Marie Iskra & Nicole Rusaw.

LiminalBio's tweet image. We are passionate about creating a culture in which women can develop & thrive. We do this through providing opportunities for mentorship & ensuring we #embraceequity throughout the organisation. This year we would like to highlight experiences of Marie Iskra & Nicole Rusaw.
LiminalBio's tweet image. We are passionate about creating a culture in which women can develop & thrive. We do this through providing opportunities for mentorship & ensuring we #embraceequity throughout the organisation. This year we would like to highlight experiences of Marie Iskra & Nicole Rusaw.
0
0
2
0
81
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Feb 15, 2023

Liminal BioSciences Regains Compliance with #NASDAQ Minimum Bid Price Requirement. Read More: loom.ly/wTFutTA #BiotechNews #LMNL

LiminalBio's tweet image. Liminal BioSciences Regains Compliance with #NASDAQ Minimum Bid Price Requirement. Read More: loom.ly/wTFutTA #BiotechNews #LMNL
0
0
0
0
49
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Feb 1, 2023

Don't miss #LMNL company presentation at this year's BIO CEO Conference taking place on 7th February in the Winter Garden room where we will be discussing key milestones in our development pipeline. To book a meeting, find Liminal BioSciences in the Bio 1x1 Partnering system.

LiminalBio's tweet image. Don't miss #LMNL company presentation at this year's BIO CEO Conference taking place on 7th February in the Winter Garden room where we will be discussing key milestones in our development pipeline. To book a meeting, find Liminal BioSciences in the Bio 1x1 Partnering system.
0
0
3
0
198
LiminalBio's profile picture.
Liminal BioSciences
 @LiminalBio
Jan 26, 2023

Liminal BioSciences announces an effective date for its Reverse Stock Split. The Company's post-consolidation Common Shares, will become effective at the opening of trading on @Nasdaq on February 1, 2023. Read more: loom.ly/0bmmcLA #LMNL #NASDAQ BiotechNews

LiminalBio's tweet image. Liminal BioSciences announces an effective date for its Reverse Stock Split. The Company's post-consolidation Common Shares, will become effective at the opening of trading on @Nasdaq on February 1, 2023. Read more: loom.ly/0bmmcLA #LMNL #NASDAQ BiotechNews
0
0
0
0
63
ActionPFsteve's profile picture. Trustee of @ActionPFcharity, a patient organisation committed to supporting people living with pulmonary fibrosis. Board member of @EU_IPFF

Steve Jones

@ActionPFsteve
IAmBiotech's profile picture. I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech

Biotechnology Innovation Organization

@IAmBiotech
michael_gilman's profile picture. Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...

Michael Gilman

@michael_gilman
erickalfaro's profile picture. the future is going to be amazing

Erick Alfαro

@erickalfaro
msuster's profile picture. 2x entrepreneur. Sold both companies (last to @salesforce). Now @UpfrontVC looking to invest in passionate entrepreneurs.

Mark Suster

@msuster
MonicaTincopa's profile picture. Transplant Hepatologist Clinical Researcher @UCSDHealth @HopkinsMedicine alum Co-founder La LiGaH #MASLD #MASH #LiverTransplant #Obesity #HealthDisparities

Mónica Tincopa MD MSc

@MonicaTincopa
marurinella's profile picture. Hepatologist, University of Chicago, proud Mexican American, yogi and gourmand

Maru Rinella MD

@marurinella
Forbes's profile picture. Sign up now for Forbes' free daily newsletter for unmatched insights and exclusive reporting: https://t.co/v3UAa9BzAT

Forbes

@Forbes
LifeSciVC's profile picture. Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.

Bruce Booth

@LifeSciVC
hannahkuchler's profile picture. Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK.

Hannah Kuchler

@hannahkuchler
bruce_pritchard's profile picture. CEO at Liminal BioSciences

Bruce Pritchard

@bruce_pritchard
ASH_hematology's profile picture. The American Society of Hematology (ASH) is the world's largest professional society concerned with the causes and treatments of blood disorders.

ASH

@ASH_hematology
IPFdoc's profile picture. I won’t be posting here anymore. if you are interested in what I have to share catch up with me @ipfdoc.bsky.social #GoodLuck

Gisli Jenkins

@IPFdoc
lungtaskforce's profile picture. Our mission: To prevent more people from developing lung disease and transform the care of people living with lung disease in England. #TaskforceforLungHealth

Taskforce For Lung Health

@lungtaskforce
PFTrust's profile picture. The aim of the Pulmonary Fibrosis Trust is to provide personal support to people affected by Pulmonary Fibrosis, a very debilitating and life-limiting illness.

PF Trust

@PFTrust
ActionPFcharity's profile picture. 💜UK charity supporting people affected by pulmonary fibrosis 🧬funding research towards a better future for people living with PF 🤝together we are stronger

Action for Pulmonary Fibrosis

@ActionPFcharity
GalapagosGlobal's profile picture. We aim to transform patient outcomes through life-changing science and innovation for more years of life and quality of life | #PioneeringForPatients

Galapagos

@GalapagosGlobal
EU_IPFF's profile picture. The European Pulmonary Fibrosis Federation (EU-PFF) is a European Federation of national #IPF & #PF/#Pulmonaryfibrosis patient associations.

EU-PFF

@EU_IPFF
PulmonaryNews's profile picture. Your source for pulmonary hypertension news, support, & real stories from the community. Let's raise awareness together!🎗️

Pulmonary Hypertension News

@PulmonaryNews
PFWarrior's profile picture. PF Warriors is a global support network that provides education, inspiration, and hope to individuals and families affected by pulmonary fibrosis.

Pulmonary Fibrosis Warrior

@PFWarrior
pharmaphorum's profile picture. https://t.co/O0ZJQGuINh, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate

pharmaphorum

@pharmaphorum
ventilacionmeca's profile picture. Medicina Intensiva. Soporte respiratorio. Rock. Pádel y Pickleball.

Fede Gordo-Vidal

@ventilacionmeca
EduardArgudo's profile picture. Intensivist-ECMOlogist-HEMS Doc | @vallhebron ICU | ECMO retrieval I ECPR-ALS-Resuscitation | Associate Professor @UniBarcelona | Clinical Simulation I MedEd

Eduard Argudo

@EduardArgudo
ErinAnderssen's profile picture. Globe and Mail writer who covers mental health and social issues. Proud partner, mom and Nova Scotian. Contact at eanderssen@globeandmail.com

Erin Anderssen

@ErinAnderssen
NEJM's profile picture. The New England Journal of Medicine is the world’s leading medical journal and website.

NEJM

@NEJM
IPFCatalyst's profile picture. Idiopathic Pulmonary Fibrosis (IPF) has ravaged countless individuals. We’re taking a stand to improve the quality of life for #IPF patients. #IPFChallenge

IPF Catalyst

@IPFCatalyst
atscommunity's profile picture. The ATS is a leading medical association dedicated to advancing pulmonary, critical care and sleep medicine globally, with more than 30,000 members.

American Thoracic Society (ATS)

@atscommunity
Healthline's profile picture. We’re committed to being your trusted ally in your pursuit of health and well-being. Count on us for information, guidance, inspiration, and genuine caring. 🌱

Healthline

@Healthline
PSRorphan's profile picture. We’ve moved! PSR Orphan Experts is now Ergomed. To stay updated on future news, please follow us on the Ergomed Twitter page at https://t.co/mWUAHD63Iq

PSR Orphan Experts (now Ergomed)

@PSRorphan
react_community's profile picture. #RAREvolution #REACTCongress. This channel is no longer fed. This channel is no longer fed. Follow us on https://t.co/mi6vAAQBDb

RE(ACT) Community

@react_community
RareDayUS's profile picture. 2/28/19. #ShowYourStripes & join the movement in the US & around the world for #RareDiseaseDay. (Hosted in the US by @RareDiseases.)

Rare Disease Day US

@RareDayUS
Breathingmatter's profile picture. Our mission is to raise awareness and inspire fundraising for research into pulmonary fibrosis and lung infection, supporting research at UCL Respiratory

Breathing Matters

@Breathingmatter
AS_UK's profile picture. 'Alström Syndrome is a rare genetic condition affecting every organ in the body. ASUK provides support & guidance for those affected.' Tweets by Catherine Lewis

Alström Syndrome UK

@AS_UK
TodayIpf's profile picture.

IPF Today

@TodayIpf
PFFORG's profile picture. We imagine a world without pulmonary fibrosis. https://t.co/e5cmq67fNV

Pulmonary Fibrosis Foundation

@PFFORG
RareRevolutionM's profile picture. Digital magazine giving a voice to those affected by rare conditions and the charities that support them. Contact us: hello@rarerevolutionmagazine.com

RARE Revolution Magazine®

@RareRevolutionM
SteveFDA's profile picture. 24th Commissioner of Food and Drugs - @US_FDA This account is now archived.

Dr. Stephen M. Hahn

@SteveFDA
PlasmaProteins's profile picture. Advocating, educating, & collaborating to bring lifesaving #plasma protein therapies to patients around the 🌎. @PPTAEurope #PlasmaDonorsSaveLives

PPTA

@PlasmaProteins
AmDiabetesAssn's profile picture. We are about diabetes & obesity: research, prevention, access to health care, & ending discrimination. Explore ADA’s Community Guidelines: https://t.co/u9o0jbt0Nb

American Diabetes Association

@AmDiabetesAssn
prof_brunt's profile picture. Translational Medicine, NBpoli CdnPoli ᑲᐁᐧᒉᐊᐧᑲᐣᐸᔦᐦᐅᕁ (Ally) in Truth & Reconciliation TRC. Amplifying 1001+ voices. Tenured. Imperfect. 🧪🦋

Dr. Keith R. Brunt

@prof_brunt
IPFawareness's profile picture. Aiming to increase awareness of Pulmonary Fibrosis, support charities in helping improve the outcomes and quality of life for patients with this disease

IPF Awareness

@IPFawareness
Ataxia_and_Me's profile picture. #Ataxia is a #raredisease affecting #Balance #Speech and #Coordination #Patients Helping Patients #MovementDisorder #Health #Medical #pharma

Ataxia and Me CIO 1184030

@Ataxia_and_Me
RarelyYours's profile picture. Tweets by Stephanie Fischer, rare disease advocate & stroke survivor sharing info & resources to engage #raredisease community. Opinions my own.

Rare Point of View

@RarelyYours
StockWolfCom's profile picture. Stats & Numbers. For education only, not a recommendation to buy/sell/hold. Do your own DD. OTC only. Tweets are automated from data, not posted manually

StockWolf

@StockWolfCom
AcademyEyeSmart's profile picture. Raising awareness of eye diseases and conditions, EyeSmart is a public information program of the American Academy of Ophthalmology.

EyeSmart

@AcademyEyeSmart
SharpIndex's profile picture. Healthcare can be the healthiest place to work 501c 3 nonprofit dedicated to healthcare #mentalhealth. https://t.co/fAFeQi96bk #physicians #Healthcare

Sharp Index

@SharpIndex
HCA_QI_Partner's profile picture. Healthcentric Advisors is a nationally-recognized, nonprofit health care quality improvement organization.

Healthcentric Advisors

@HCA_QI_Partner
jenna_pay's profile picture. You read medical news, I write it | @neurology_live Editor | Proud @UofSC alum | #Jerseygirl | Email: jpayesko@neurologylive.com

Jenna Payesko

@jenna_pay
Loftus's profile picture. Wall Street Journal @WSJ reporter - pharmaceuticals, medical devices, healthcare. peter.loftus@wsj.com. Author of The Messenger

Peter Loftus

@Loftus
MaverickNY's profile picture. Scientist, oncology geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football

Sally Church

@MaverickNY

United States Trends

You might like

Something went wrong.


Something went wrong.